Back Derivatives Strategy

Post FOMC Weekly Volatility Update

Published on September 22, 2024

∙ Download the PDF Report

By

Jeff Jacobson

Following the Fed meeting I continue to favor owning cheap upside calls in areas of the market that I believe have further upside, while limiting risk in case of a market turn. Along those lines, I wanted to highlight three trades I like the setup for as we head into a new trading week and into Q4:

Buy SPY Oct 582 calls for $2.50 (SPY 568.25 ref)

As expected, implied volatility across the board moved lower after the Fed announcement Wed afternoon. The 1-month (October) at the money SPY vol traded down from about 14 and closed the week at just over 12, which has essentially been the lows for front-month vol since July (upside 25-delta call vol is even lower at ~ 10.75). The argument for owning upside calls in SPY here, besides being cheap on an implied vol basis, is that they continue to trade at a discount to 20-day realized vol (currently ~ 14.60). The market broke out on Thursday above the July/Aug highs and the small pullback on Friday, following the huge jump on Thursday and the disappointing Fedex news, should also be viewed as bullish.

I also like the setup to own upside calls with an October expiry since most/all of the largest tech companies in SPX won’t report earnings until after the Oct 18th expiration. Without the potential for earnings to derail this latest rally, perhaps the market can continue the upside move now that the Fed has started to finally cut rates? Lastly, October has been a much better month for stocks than September with a 2.54% average gain over the last 5 years (vs the 4.46% average decline in September). A rally to new highs to start Q4 certainly doesn’t seem out of the question.

Owning “cheap” upside calls in this tape for the next month gives buyers some flexibility should the market continue its ascent higher. Should we see further gains you can look to lighten up current equity long holdings ahead of earnings and the election (while still maintaining overall long exposure). Otherwise, you can monetize any gains as upside vol is unlikely to go much lower given the already low historical level it currently trades at.

SPY 25-delta 1-month call implied vol continues to trade at a substantial discount to 20-day realized vol

SPY broke out above the July/Aug highs to new all-time highs on Thursday

Buy XBI Oct 105 calls for $1.55 – $1.60 (XBI 101.61 ref)

This trade is a bit more speculative than buying SPY calls, but the risk/reward looks very attractive. The main biotech etf (XBI) has been knocking up against long-term resistance for some time. A breakout above 103-104 should confirm the move higher and will likely bring in more momentum buyers. Much like SPY, implied vol has also been coming in for the XBI upside calls. At a current implied vol ~ 24 that is not only down ~ 10 vol points from the Aug highs, but when XBI was attempting to break out above this level in Feb-March, the 5% upside calls were trading at a vol closer to 30-32.

The Fed cutting rates should also bolster sentiment for the biotechs as they generally benefit from lower short-term rates given their borrowing needs. This trade also aligns with 22V’s current view that the market rally will continue to broaden out. XBI is still down 40% from the 2021 highs, and perhaps some of the money that has gone into the more defensive pharma names will rotate back into this area of healthcare? Lastly, given the more speculative nature of biotechs, I believe we may even see upside call vol move higher on a real breakout for the space (another reason I like the risk/reward to buying XBI upside calls here).

XBI looks poised for a meaningful breakout above the 103-104 level

XBI 1-month 25-delta call vol is down 10 points from the Aug highs and just above the 1-year lows

Buy GLD Nov 255 calls for $2.50 (GLD 242.21 ref)

I mentioned GLD upsides last week but want to reiterate that I strongly favor owning upside calls here thru the election. Gold had another good week last week (up 1.5%) and continues to make new all-time highs on what seems like a daily basis. The US$ index (DXY) is still sitting right above the 2-year lows ~ 100, and perhaps a break below that level could be the catalyst to see a BIG move higher in gold?

What continues to stand out to me is that even with the consistent bid to gold, upside call vol remains “fair to cheap”. Back in April, when GLD spiked from about to 200 to 220, we saw the 2-month 25-delta call vol move up to as much as 20. I think we can see a similar-type move in upside call vol (as gold also moves higher) should gold make that next big move up. I favor the Nov calls since that also captures the upcoming election. These calls can be added to an existing long gold position, or as an upside kicker given how well gold acts, and potential for further highs.

Gold (GLD) closed at another new all-time high on Friday

GLD 2-month 25-delta call vol is still well below the April highs (also when gold was rallying)

The US$ index (DXY) continues to sit just above the 2-year lows

DISCLOSURES AND DISCLAIMERS

Analyst Certification

The analyst, 22V Research Group, primarily responsible for the preparation of this research report attests to the following: (1) that the views and opinions rendered in this research report reflect his or her personal views about the subject companies or issuers; and (2) that no part of the research analyst’s compensation was, is, or will be directly related to the specific recommendations or views in this research report.

Analyst Certifications and Independence of Research.

Each of the 22V Research analysts whose names appear on the front page of this report hereby certify that all the views expressed in this Report accurately reflect our personal views about any and all of the subject securities or issuers and that no part of our compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views of in this Report.

22V Research (the “Company”) is an independent research provider. The Company is not a member of the FINRA or the SIPC and is not a registered broker dealer or investment adviser. 22V Research has no other regulated or unregulated business activities which conflict with its provision of independent research.

22V Research, LLC is a professional services and independent publication organization. 22V Research, LLC is not a securities broker-dealer, not a member of the Financial Industry Regulatory Authority (FINRA), not a registered investment advisor (RIA) and not a member of SIPC.

Securities transactions, when offered, are offered by 22V Securities, LLC through LPS Capital, LLC. Certain employees of 22V Securities, LLC are dually registered as securities representatives of LPS Capital, LLC or Analyst Hub Securities, LLC. 22V Securities, LPS Capital and Analyst Hub Securities are members FINRA, SIPC.

https://brokercheck.finra.org/

Current Ratings Definition.

SECTOR OUTPERFORM: An “outperform” rating anticipates the company will outperform the S&P Regional Banking Index (peer group).

SECTOR PERFORM: A “market perform” rating anticipates the company will perform in line with the S&P Regional Banking Index (peer group).

SECTOR UNDERPERFORM: An “underperform” rating anticipates the company will underperform the S&P Regional Banking Index (peer group).

Limitation Of Research And Information.

This Report has been prepared for distribution to only qualified institutional or professional clients of 22V Research Group. The contents of this Report represent the views, opinions, and analyses of its authors. The information contained herein does not constitute financial, legal, tax or any other advice. All third-party data presented herein were obtained from publicly available sources which are believed to be reliable; however, the Company makes no warranty, express or implied, concerning the accuracy or completeness of such information. In no event shall the Company be responsible or liable for the correctness of, or update to, any such material or for any damage or lost opportunities resulting from use of this data. Nothing contained in this Report or any distribution by the Company should be construed as any offer to sell, or any solicitation of an offer to buy, any security or investment. Any research or other material received should not be construed as individualized investment advice. Investment decisions should be made as part of an overall portfolio strategy and you should consult with a professional financial advisor, legal and tax advisor prior to making any investment decision. 22V Research Group shall not be liable for any direct or indirect, incidental or consequential loss or damage (including loss of profits, revenue or goodwill) arising from any investment decisions based on information or research obtained from 22V Research Group.

Reproduction And Distribution Strictly Prohibited.

No user of this Report may reproduce, modify, copy, distribute, sell, resell, transmit, transfer, license, assign or publish the Report itself or any information contained therein. Notwithstanding the foregoing, clients with access to working models are permitted to alter or modify the information contained therein, provided that it is solely for such client’s own use. This Report is not intended to be available or distributed for any purpose that would be deemed unlawful or otherwise prohibited by any local, state, national or international laws or regulations or would otherwise subject the Company to registration or regulation of any kind within such jurisdiction.

Copyrights, Trademarks, Intellectual Property.

22V Research Group, and any logos or marks included in this Report are proprietary materials. The use of such terms and logos and marks without the express written consent of 22V Research Group is strictly prohibited. The copyright in the pages or in the screens of the Report, and in the information and material therein, is proprietary material owned by 22V Research Group unless otherwise indicated. The unauthorized use of any material on this Report may violate numerous statutes, regulations and laws, including, but not limited to, copyright, trademark, trade secret or patent laws.